AstraZeneca has made an important change to one of its inhalers, Breztri, used for treating COPD (a lung condition), by switching to a new, environmentally friendly propellant.
Aedifica NV/SA invested £61.5 million in 4 UK care homes, acquiring 3 existing ones and a future one. The press release details the acquisition by the Belgian real estate company.
Swiss Re anticipates higher demand for reinsurance due to increased risks in property, specialty lines, and casualty, focusing on refined data, capital management, and protection against natural disasters.
New data from the 15th European Epilepsy Congress reveals significant delays in diagnosing Lennox-Gastaut syndrome (LGS) and its heavy disease burden.
AstraZeneca shared results from a study showing TROP2 biomarker's predictive value in lung cancer patients treated with datopotamab deruxtecan. This biomarker was measured using AstraZeneca's computational pathology platform, and the…
Munich Re sees the market environment for reinsurers "promising and challenging at the same time", the company said at the “Rendez-Vous de Septembre” industry event in Monte Carlo.
Merck & Co. reports Ifinatamab Deruxtecan shows promising response rates in Phase 2 IDeate-Lung01 trial for extensive-stage small cell lung cancer..
Swiss Re's Social Inflation Index attributes the rise to large court verdicts, increased litigation funding, and legislative trends.
CD Projekt S.A. otrzymał informację o pozwie zbiorowym złożonym w USA przeciwko jego spółce zależnej GOG, dotyczącym rozwiązań technicznych oraz zgodności z amerykańską ustawą o ochronie prywatności wideo.
CD Project S.A. received information about a class action lawsuit filed in the US against its subsidiary GOG regarding technical solutions and compliance with the US Video Privacy Protection Act.